CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Lantheus Holdings Inc - LNTH CFD

60.73
1.16%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.13
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Lantheus Holdings Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 61.44
Open* 60.98
1-Year Change* -29.22%
Day's Range* 59.6 - 61.06
52 wk Range 53.37-100.85
Average Volume (10 days) 1.41M
Average Volume (3 months) 24.63M
Market Cap 3.77B
P/E Ratio 38.53
Shares Outstanding 68.49M
Revenue 1.21B
EPS 1.43
Dividend (Yield %) N/A
Beta 0.54
Next Earnings Date Feb 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 60.73 0.09 0.15% 60.64 61.12 59.60
Apr 11, 2024 61.44 1.51 2.52% 59.93 61.81 59.83
Apr 10, 2024 59.81 1.33 2.27% 58.48 60.18 58.22
Apr 9, 2024 60.36 0.68 1.14% 59.68 60.98 59.49
Apr 8, 2024 59.67 0.16 0.27% 59.51 60.60 59.04
Apr 5, 2024 60.76 1.62 2.74% 59.14 60.87 59.13
Apr 4, 2024 59.63 -0.34 -0.57% 59.97 60.49 59.14
Apr 3, 2024 59.14 0.60 1.02% 58.54 59.94 58.34
Apr 2, 2024 58.79 0.30 0.51% 58.49 59.11 58.07
Apr 1, 2024 60.05 -1.84 -2.97% 61.89 61.89 59.56
Mar 28, 2024 62.15 1.90 3.15% 60.25 62.40 60.24
Mar 27, 2024 60.38 0.88 1.48% 59.50 60.46 59.14
Mar 26, 2024 58.68 -0.32 -0.54% 59.00 59.29 57.82
Mar 25, 2024 58.94 -0.04 -0.07% 58.98 60.13 58.77
Mar 22, 2024 58.94 0.75 1.29% 58.19 60.04 58.03
Mar 21, 2024 58.63 -0.99 -1.66% 59.62 59.86 58.56
Mar 20, 2024 59.10 1.16 2.00% 57.94 59.19 57.69
Mar 19, 2024 58.38 1.67 2.94% 56.71 59.30 56.47
Mar 18, 2024 56.45 -1.73 -2.97% 58.18 58.22 56.38
Mar 15, 2024 58.13 -1.56 -2.61% 59.69 60.45 57.72

Lantheus Holdings Inc Events

Time (UTC) Country Event
Thursday, April 25, 2024

Time (UTC)

14:30

Country

US

Event

Lantheus Holdings Inc Annual Shareholders Meeting
Lantheus Holdings Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Friday, April 26, 2024

Time (UTC)

14:30

Country

US

Event

Lantheus Holdings Inc Annual Shareholders Meeting
Lantheus Holdings Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, May 2, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Lantheus Holdings Inc Earnings Release
Q1 2024 Lantheus Holdings Inc Earnings Release

Forecast

-

Previous

-
Thursday, August 1, 2024

Time (UTC)

12:30

Country

US

Event

Q2 2024 Lantheus Holdings Inc Earnings Release
Q2 2024 Lantheus Holdings Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 935.061 425.208 339.41 347.337 343.374
Revenue 935.061 425.208 339.41 347.337 343.374
Cost of Revenue, Total 353.358 237.513 191.049 172.526 168.489
Gross Profit 581.703 187.695 148.361 174.811 174.885
Total Operating Expense 899.454 485.144 343.608 298.872 278.886
Selling/General/Admin. Expenses, Total 233.827 218.817 98.271 103.132 93.326
Research & Development 311.681 44.966 30.088 20.018 17.071
Unusual Expense (Income) 0.588 -16.152 24.2 3.196 0
Operating Income 35.607 -59.936 -4.198 48.465 64.488
Interest Income (Expense), Net Non-Operating 0.666 -7.981 -9.501 -12.964 -17.962
Other, Net -9.554 -7.121 2.22 -6.874 3.022
Net Income Before Taxes 26.719 -75.038 -11.479 28.627 49.548
Net Income After Taxes 28.067 -71.279 -13.473 31.667 40.518
Net Income Before Extra. Items 28.067 -71.279 -13.473 31.667 40.518
Net Income 28.067 -71.279 -13.473 31.667 40.518
Income Available to Common Excl. Extra. Items 28.067 -71.279 -13.473 31.667 40.518
Income Available to Common Incl. Extra. Items 28.067 -71.279 -13.473 31.667 40.518
Diluted Net Income 28.067 -71.279 -13.473 31.667 40.518
Diluted Weighted Average Shares 70.671 67.486 54.134 40.113 39.501
Diluted EPS Excluding Extraordinary Items 0.39715 -1.0562 -0.24888 0.78944 1.02575
Diluted Normalized EPS 0.40256 -1.21177 0.04169 0.84123 1.02575
Total Extraordinary Items
Dividends per Share - Common Stock Primary Issue
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 321.7 300.784 263.166 239.292 223.723
Revenue 321.7 300.784 263.166 239.292 223.723
Cost of Revenue, Total 119.053 107.308 95.995 91.859 85.694
Gross Profit 202.647 193.476 167.171 147.433 138.029
Total Operating Expense 197.561 310.128 435.431 153.549 160.519
Selling/General/Admin. Expenses, Total 62.607 55.888 66.622 49.173 60.09
Research & Development 15.901 14.932 272.226 12.517 14.735
Unusual Expense (Income) 132 0.588 0 0
Operating Income 124.139 -9.344 -172.265 85.743 63.204
Interest Income (Expense), Net Non-Operating -0.682 -1.714 -0.586 -1.267 -1.555
Other, Net 0.231 -0.046 -3.392 -1.46 0.396
Net Income Before Taxes 123.688 -11.104 -176.243 83.016 62.045
Net Income After Taxes 94.131 -2.807 -119.185 61.232 43.058
Net Income Before Extra. Items 94.131 -2.807 -119.185 61.232 43.058
Net Income 94.131 -2.807 -119.185 61.232 43.058
Income Available to Common Excl. Extra. Items 94.131 -2.807 -119.185 61.232 43.058
Income Available to Common Incl. Extra. Items 94.131 -2.807 -119.185 61.232 43.058
Diluted Net Income 94.131 -2.807 -119.185 61.232 43.058
Diluted Weighted Average Shares 71.014 67.749 68.502 71.075 70.796
Diluted EPS Excluding Extraordinary Items 1.32553 -0.04143 -1.73988 0.86151 0.6082
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 1.32553 1.22501 -1.7343 0.86151 0.6082
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 677.616 235.791 184.225 172.911 195.415
Cash and Short Term Investments 415.652 98.508 79.612 92.919 113.401
Cash & Equivalents 415.652 98.508 79.612 92.919 113.401
Total Receivables, Net 213.397 89.336 54.002 43.529 43.753
Accounts Receivable - Trade, Net 213.397 89.336 54.002 43.529 43.753
Total Inventory 35.475 35.129 35.744 29.18 33.019
Other Current Assets, Total 13.092 12.818 14.867 7.283 5.242
Total Assets 1321.26 863.784 869.821 405.919 439.831
Property/Plant/Equipment, Total - Net 141.199 125.56 138.612 117.432 107.888
Property/Plant/Equipment, Total - Gross 241.327 214.475 215.024 209.087 190.627
Accumulated Depreciation, Total -100.128 -88.915 -76.412 -91.655 -82.739
Goodwill, Net 61.189 61.189 58.632 15.714 15.714
Intangibles, Net 315.285 348.51 376.012 7.336 9.134
Other Long Term Assets, Total 125.969 92.734 112.34 92.526 111.68
Total Current Liabilities 247.701 90.497 80.504 66.111 52.755
Accounts Payable 20.563 20.787 16.284 18.608 17.955
Accrued Expenses 203.436 54.313 36.761 37.36 32.05
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.354 11.642 20.701 10.143 2.75
Other Current Liabilities, Total 23.348 3.755 6.758
Total Liabilities 874.111 399.345 355.616 291.318 368.829
Total Long Term Debt 557.712 163.121 197.699 183.927 263.709
Long Term Debt 557.481 162.822 197.453 183.741 263.709
Other Liabilities, Total 68.698 145.727 77.413 41.28 52.365
Total Equity 447.147 464.439 514.205 114.601 71.002
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.689 0.677 0.669 0.393 0.385
Additional Paid-In Capital 715.875 685.472 665.53 251.641 239.865
Retained Earnings (Accumulated Deficit) -193.158 -221.225 -149.946 -136.473 -168.14
Other Equity, Total -1.259 -0.485 -2.048 -0.96 -1.108
Total Liabilities & Shareholders’ Equity 1321.26 863.784 869.821 405.919 439.831
Total Common Shares Outstanding 68.851 67.739 66.875 39.251 38.466
Treasury Stock - Common -75 0 0 0
Capital Lease Obligations 0.231 0.299 0.246 0.186
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 948.435 752.219 773.274 677.616 501.898
Cash and Short Term Investments 614.131 414.076 470.863 415.652 257.259
Cash & Equivalents 614.131 414.076 470.863 415.652 257.259
Total Receivables, Net 259.198 256.277 242.106 213.397 197.276
Accounts Receivable - Trade, Net 259.198 256.277 242.106 213.397 197.276
Total Inventory 56.462 51.801 42.156 35.475 34.793
Other Current Assets, Total 18.644 30.065 18.149 13.092 12.57
Total Assets 1521.61 1337.72 1349.28 1321.26 1095.94
Property/Plant/Equipment, Total - Net 186.203 154.186 146.036 141.199 129.119
Property/Plant/Equipment, Total - Gross 290.268 255.126 246.065 241.327 226.405
Accumulated Depreciation, Total -104.065 -100.94 -100.029 -100.128 -97.286
Goodwill, Net 61.189 61.189 61.189 61.189 61.189
Intangibles, Net 163.294 221.004 219.863 315.285 323.591
Other Long Term Assets, Total 162.489 149.122 148.922 125.969 80.141
Total Current Liabilities 176.602 154.043 276.388 247.701 235.984
Accounts Payable 37.076 38.861 30.798 20.563 30.135
Accrued Expenses 118.066 105.241 197.086 203.436 181.01
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.703 0.384 0.422 0.354 15.372
Other Current Liabilities, Total 20.757 9.557 48.082 23.348 9.467
Total Liabilities 822.851 785.075 903.768 874.111 457.888
Total Long Term Debt 560.576 559.235 558.536 557.712 152.057
Long Term Debt 560.154 559.235 558.372 557.481 151.851
Other Liabilities, Total 85.673 71.797 68.844 68.698 69.847
Total Equity 698.759 552.645 445.516 447.147 638.05
Common Stock 0.698 0.698 0.696 0.689 0.688
Additional Paid-In Capital 743.973 729.733 717.163 715.875 708.341
Retained Earnings (Accumulated Deficit) 30.123 -101.834 -195.965 -193.158 -73.973
Treasury Stock - Common -75 -75 -75 -75
Unrealized Gain (Loss)
Other Equity, Total -1.035 -0.952 -1.378 -1.259 2.994
Total Liabilities & Shareholders’ Equity 1521.61 1337.72 1349.28 1321.26 1095.94
Total Common Shares Outstanding 69.808 69.755 69.63 68.851 68.809
Capital Lease Obligations 0.422 0.164 0.231 0.206
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 28.067 -71.279 -13.473 31.667 40.518
Cash From Operating Activities 281.781 53.916 16.396 80.384 61.193
Cash From Operating Activities 47.929 42.288 24.689 13.379 13.929
Non-Cash Items 328.333 93.624 28.879 16.564 14.956
Cash Taxes Paid 54.049 0.215 0.34 0.274 0.09
Cash Interest Paid 5.064 6.284 9.368 12.253 15.869
Changes in Working Capital -74.532 -15.154 -22.365 9.049 -13.972
Cash From Investing Activities -276.547 3.683 -4.912 -22.061 -19.132
Capital Expenditures -18.347 -12.14 -12.474 -22.061 -20.132
Other Investing Cash Flow Items, Total -258.2 15.823 7.562 0 1
Cash From Financing Activities 311.691 -39.332 -21.861 -78.881 -4.668
Financing Cash Flow Items -4.586 -2.046 -7.13 -4.712 -3.386
Issuance (Retirement) of Stock, Net -66.088 6.062 0.76 1.746 1.58
Issuance (Retirement) of Debt, Net 382.365 -43.348 -15.491 -75.915 -2.862
Foreign Exchange Effects -0.335 -0.31 0.152 0.076 -0.282
Net Change in Cash 316.59 17.957 -10.225 -20.482 37.111
Deferred Taxes -48.016 4.437 -1.334 9.725 5.762
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -2.807 28.067 147.252 86.02 42.962
Cash From Operating Activities 108.5 281.781 176.429 82.861 10.264
Cash From Operating Activities 14.615 47.929 36.048 23.893 11.786
Deferred Taxes -35.863 -48.016 14.461 6.598 14.18
Non-Cash Items 143.333 328.333 56.269 46.111 27.76
Changes in Working Capital -10.778 -74.532 -77.601 -79.761 -86.424
Cash From Investing Activities -44.513 -276.547 -11.823 -5.733 -1.39
Capital Expenditures -9.168 -18.347 -13.623 -7.533 -3.19
Other Investing Cash Flow Items, Total -35.345 -258.2 1.8 1.8 1.8
Cash From Financing Activities -8.669 311.691 -6.149 -4.19 -2.179
Financing Cash Flow Items -11.154 -4.586 -7.171 -6.328 -5.504
Issuance (Retirement) of Stock, Net 2.782 -66.088 8.913 7.357 5.934
Issuance (Retirement) of Debt, Net -0.297 382.365 -7.891 -5.219 -2.609
Foreign Exchange Effects -0.098 -0.335 -0.266 -0.019 0.151
Net Change in Cash 55.22 316.59 158.191 72.919 6.846
Cash Taxes Paid
Cash Interest Paid

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Lantheus Holdings Inc Company profile

About Lantheus Holdings Inc

Lantheus Holdings, Inc. is a provider of imaging diagnostics, targeted therapeutics, and artificial intelligence solutions to Find, Fight and Follow serious medical conditions. It operates through two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its agents and products throughout the United States. The International Segment operations consist of direct distribution in Canada and Puerto Rico, as well as third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific and Latin America and its EXINI business in Sweden. The Company sells its products to radio pharmacies, PET manufacturing facilities (PMFs), integrated delivery networks, hospitals, clinics and group practices. Its commercial portfolio includes DEFINITY, TechneLite, NEUROLITE, RELISTOR, Xenon-133, Cardiolite, Gallium-67, Thallium-201, AZEDRA, QUADRAMET, Cobalt and Automated Bone Scan Index (aBSI).

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Lantheus Holdings Inc revenues increased 25% to $425.2M. Net loss increased from $13.5M to $71.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Other General and administrative increase from $50M to $141.3M (expense), Other Sales and marketing expense increase of 69% to $66M (expense).

Industry: Laboratory Diagnostic & Testing Substances

331 Treble Cove Rd
NORTH BILLERICA
MASSACHUSETTS 01862
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

XRP/USD

0.55 Price
+0.650% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

18,006.40 Price
-1.660% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Gold

2,344.52 Price
-1.190% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.50

ETH/USD

3,259.33 Price
+0.930% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading